The HDSA Podcast podcast

S4:E11 Let's talk about the AMT-130 Update

0:00
8:42
15 Sekunden vorwärts
15 Sekunden vorwärts

Send us Fan Mail

Tam Maiuri, MaryAnn Emerick, and Allison Bartlett touch base on uniQure’s announcement that the FDA has accepted its application for AMT-130 and granted Priority Review, with a target action date of May 1, 2027. Join them for a brief conversation about this latest development for the Huntington’s disease community.

Don't forget to follow us on social media!

Weitere Episoden von „The HDSA Podcast“